BibTeX
CSL-JSON
MLA
Harvard
Multicenter open study with docetaxel. Treatment of patients with locally advanced or metastatic breast carcinoma
Estudo aberto multicêntrico com docetaxel. Tratamento de doentes com carcinoma da mama localmente avançado ou metastático
release_pthvt4rrungnjhacw6ygxrefhq
by
O Campos,
I Gonçalves,
I Furtado,
J Espírito Santo,
A Alcazar,
A Pinguinha,
A Fráguas,
M Chumbo,
M J Cunha,
A Gouveia-Oliveira
Published
in Acta Médica Portuguesa
.
Volume 14, Issue 4, p375-80
Abstract
The efficacy and safety of docetaxel were evaluated in an open, multicentric, non comparative study involving 24 patients with locally advanced or metastatic breast cancer, eligible for second line or subsequent anticancer chemotherapy; the results confirm a global response around 50%, suggesting some advantages when compared to the usual treatments in this set of patients; the median duration of response, the median time to progression and the median time of survival were respectively, 309, 219 and 345 days; the main iatrogenic event was haematological, mainly in the white and red blood cells.
In text/plain format
Archived Files and Locations
application/pdf
438.9 kB
file_7dw5ljggrrgoxmoqkkbisfo6pu
|
www.actamedicaportuguesa.com (web) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
PubMed
11762177
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
0870-399X
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links